A case of nonscarring subepidermal blistering disease associated with autoantibodies reactive with both type VII collagen and laminin 5

Dermatology

Volumn 207, Issue 1, 2003, Pages 61-64

  Umemoto, Naoka ^a   Demitsu, Toshio ^a   Toda, Sunao ^a   Ohsawa, Masumi ^a   Noguchi, Tadahide ^a   Kakurai, Maki ^a   Yamada, Tomoko ^a   Suzuki, Masayuki ^a   Nakagawa, Hidemi ^a   Komai, Ayako ^b   Hashimoto, Takashi ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti laminin 5 cicatricial pemphigoid; Epidermolysis bullosa acquisita; Epilligrin; Immunoblotting analysis; Type VII collagen

Indexed keywords

AUTOANTIBODY; AZATHIOPRINE; BETAMETHASONE; COLLAGEN TYPE 4; COMPLEMENT COMPONENT C3; CORTICOSTEROID; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; KALININ; PREDNISOLONE; SODIUM CHLORIDE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; BLISTER; BLOOD ANALYSIS; BULLOUS SKIN DISEASE; CASE REPORT; CELL DEGENERATION; DISEASE ASSOCIATION; EPIDERMIS; FEMALE; GENITAL TRACT INFECTION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LABORATORY TEST; MOUTH LESION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PRURITUS; RECURRENT DISEASE; SERUM; SKIN BIOPSY; SKIN DEFECT; SKIN SCAR; SKIN TEST;

ADULT; AUTOANTIBODIES; AZATHIOPRINE; BETAMETHASONE; BIOPSY, NEEDLE; COLLAGEN TYPE VII; DRUG THERAPY, COMBINATION; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FOLLOW-UP STUDIES; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LAMININ; PREDNISOLONE; RECURRENCE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0037634476     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000070945     Document Type: Article

References (8)

1. Schmidt E, Zillikens D: Autoimmune and inherited subepidermal blistering diseases: Advances in the clinic and the laboratory. Adv Dermatol 2000;16:113-157.
2. Kawahara Y, Zillikens D, Yancey KB, Marinkovich MP, Nie Z, Hashimoto T, et al: Subepidermal blistering disease with autoantibodies against a novel dermal 200-kD antigen. J Dermatol Sci 2000;23:93-102.
3. Tanaka H, ishida-Yamamoto A, Hashimoto T, Hiramoto K, Harada T, Kawachi Y, et al: A novel variant of acquired epidermolysis bullosa with autoantibodies against the central triple-helical domain of type VII collagen. Lab Invest 1997;77:623-632.
4. Nie Z, Nagata Y, Joubeh S, Hirako Y, Owaribe K, Kitajima Y, et al: IgA antibodies of linear IgA bullous dermatosis recognize the 15th collagenous domain of BP180. J Invest Dermatol 2000;115:1164-1166.
5. Choi GS, Lee ES, Kim SC, Lee S: Epidermolysis bullosa acquisita localized to the face. J Dermatol 1998;25:19-22.
6. Zillikens D, Ishiko A, Jonkman MF, Chimanovich I, Simizu H, Hashimoto T, et al: Autoantibodies in anti-p200 pemphigoid stain skin lacking laminin 5 and type VII collagen. Br J Dermatol 2000;143:1043-1049.
7. Chan LS, Lapière JC, Chen M, Traczyk T, Mancini AJ, Paller AS, et al: Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. Arch Dermatol 1999;135:569-573.
8. Jonkman MF, Schuur J, Dijk F, Heeres K, de Jong MC, van der Meer JB, et al: Inflammatory variant of epidermolysis bullosa acquisita with IgG autoantibodies against type VII collagen and laminin alpha3. Arch Dermatol 2000;136: 227-231.